当心力衰竭隐藏了肉瘤时
Valter Duarte1, Miguel Martins1, Daniela Alves1
1Internal Medicine, Unidade Local de Saúde da Região de Aveiro, Aveiro, PRT.
Cureus
|November 27, 2025
概括
主要心脏瘤是具有侵略性的心脏瘤,以不明原因的心力衰竭或质体的形式出现. 这一案例凸显了诊断方面的挑战,以及对这些罕见癌症的更好的治疗和息护理的需求.
科学领域:
- 心脏病学 心脏病学
- 在瘤学瘤学.
- 放射学 放射学是一门学科.
背景情况:
- 初级心脏瘤是罕见的,具有不良预后的侵袭性瘤.
- 临床表现往往是不特定的,模仿其他疾病,如心力衰竭.
- 早期转移是常见的,使诊断和治疗复杂化.
研究的目的:
- 突出初级心脏肉瘤的诊断和治疗挑战.
- 强调在患有不明原因心力衰竭或心内质块的患者中考虑心脏瘤的重要性.
- 强调需要多学科管理和改进的系统治疗策略.
主要方法:
- 一个71岁的妇女的病例报告,左心房质量.
- 诊断工作包括心声回声,心脏MRI,CT和PET扫描.
- 活检证实了高等级的肉瘤.
主要成果:
- 确定了一种大型左心房肉瘤,透到二手心,导致严重的狭窄和吐.
- 由于广泛的参与,瘤被认为是无法切除的.
- 在D12脊椎体中发现了转移.
结论:
- 初级心脏肉瘤带来了重大的诊断和治疗挑战.
- 多学科护理,新的全身疗法和及时的息护理至关重要.
- 在患有不明原因的心脏症状或质量的患者中,早期考虑心脏肉瘤至关重要.
相关概念视频
Heart Failure III: Clinical Manifestations
446
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
446
Cardiomyopathy III: Hypertrophic Cardiomyopathy
374
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
374
Heart Failure II: Pathophysiology
685
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
685
Pathophysiology of Heart Failure
2.7K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.7K
Heart Failure I: Introduction
670
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
670
Cardiomyopathy V: Interprofessional Care
314
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
314


